Scientists Evaluate TROP-2 Targeted Antibody Drug Conjugates in Gynecologic Cancers
A comprehensive review examines the biology, clinical trials, and resistance mechanisms of antibody-drug conjugates targeting TROP-2 across advanced ovarian, endometrial, ...




















